Clinical and molecular complexity of breast cancer metastases

Siker Kimbung(Lund University), Ingrid Hedenfalk(Lund University), Niklas Loman(Lund University)

Seminars in Cancer Biology

August 28, 2015

10.1016/j.semcancer.2015.08.009

Cited by 156

Related Papers

Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

|The American Journal of Human Genetics|2003|3.7k

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

|The Lancet|2010|2.3k

Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation

|Journal of Clinical Oncology|2014|1.7k

An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression

|Cancer Cell|2017|534

Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer

|JAMA|2015|513